Skip to content

Sickle Cell Anemia WE CARE

Understanding and Addressing the Social Determinants of Health for Families of Children With Sickle Cell Anemia Within Pediatric Hematology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03716726
Acronym
SCAWECARE
Enrollment
112
Registered
2018-10-23
Start date
2021-01-21
Completion date
2023-02-01
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Keywords

Sickle Cell Disease, Social Determinants of Health, Unmet Social Needs, WE CARE

Brief summary

This mixed-methods study aims to understand the implementation of a previously tested, efficacious social determinants of health (SDoH) screening and referral intervention in the outpatient pediatric hematology setting; qualitatively assess possible mechanisms for such interventions on improving child health; and obtain population-specific empirical estimates to plan a large-scale clinical trial.

Detailed description

Social determinants of health (SDoH)-the conditions in which people are born, grow, work, live, and age-are key drivers of health and health disparities. Children with medical complexity are particularly at-risk given their high healthcare need and utilization. Although the American Academy of Pediatrics and payers such as the Centers for Medicaid and Medicare Services are now recommending medical providers screen for SDoH at visits, studies have not yet demonstrated the impact of SDoH screening and referral interventions on improving child health and have fallen short of exploring potential mechanisms by which such interventions could improve health outcomes. Children with sickle cell anemia (SCA) are an ideal population in which to study the impact of SDoH interventions given the high prevalence of poverty and unmet material needs among this population and the disease's significant morbidity and mortality. This proposal addresses a timely clinically- and policy-relevant research gap by: (1) implementing a SDoH intervention in two outpatient pediatric hematology clinics and gathering preliminary data to assess its impact on child health; and (2) characterizing the potential mechanisms by which addressing SDoH may lead to improved health outcomes. The research team has developed, tested, and implemented a SDOH intervention (WE CARE) which relies on existing clinical processes to screen for unmet material needs and refer parents to community services; efficacy data demonstrates its positive impact on parental receipt of community resources. The investigators now propose conducting a pragmatic pilot cluster randomized controlled trial (RCT) to examine the implementation of WE CARE as standard of care in two of the four hematology clinics. To preliminarily examine outcomes,100 parents of children with SCA (25 per site) will be recruited and followed for one year in order to explore how addressing unmet social needs within the delivery of medical care may improve healthcare utilization and health outcomes. Given the limitations of applying existing theoretical frameworks to culturally diverse populations such as those with SCA, the investigators will also employ a mixed methods approach to characterizing how SDoH influences disease management processes. The specific aims are to: (1) Implement WE CARE in two pediatric hematology clinics in order to field test key study logistics and understand the facilitators and barriers to implementation and accelerate its adoption; (2) Obtain population-specific empirical estimates of study parameters to plan a large-scale multi-site cluster RCT of WE CARE that will definitely assess its impact on improving health outcomes for children with SCA; and (3) Qualitatively assess possible mechanisms linking SDoH interventions to improved health outcomes. It has significant implications for child health policy and is a critical step in potentially transforming the delivery of healthcare for medically complex children.

Interventions

BEHAVIORALWE CARE SDoH Screening Survey

The survey will be given at all visits by the front desk staff to all parents of SCA patients. It consists of 12 questions designed to: (1) briefly identify 6 unmet material needs (e.g., childcare, employment, food security, household heat, housing inadequate education) by self-report and (2) using a family-centered approach, determine whether parents would like assistance with each problem Parents wanting help will receive a resource referral. Clinical team members will be trained to review the WE CARE SDoH survey at visits and to provide community resource information sheets to parents with needs. Completed surveys will be scanned into the EHR

BEHAVIORALFamily Resource Book

The Family Resource book will contain one-page information sheets listing community resources (e.g., food pantries) and their contact information (i.e. telephone number) for each specific material need (e.g., food insecurity). Information sheets will be specific to each site and written at, or below, the 8th grade level. For parents with an identified need, providers will be instructed to give an information sheet. The book will contain six separate tabs, one for each unmet need, and will contain multiple copies of the information sheets. The Family Resource Book will be made available in each exam room. The investigators will work with each practice to create a Family Resource Book prior to study initiation.

OTHERStandard of care

Usual outpatient care for pediatric patients with sickle cell anemia will be provided.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Boston Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Pragmatic pilot cluster RCT to examine the implementation of WE CARE as standard of care in two of the four outpatient pediatric hematology clinics.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult parents of children with SCA (0-12 years of age) who take a daily medication (penicillin or hydroxyurea)to * English or Spanish speaking

Exclusion criteria

* Foster parents

Design outcomes

Primary

MeasureTime frameDescription
Number of Emergency Department (ED)/Acute Care Visits12 monthsData on number of ED visits and acute care visits abstracted from the EHR.
Parental Enrollment in Community Resources12 monthsSelf-reported enrollment in a new community resource, where yes indicates enrollment in a new resource, and no indicates no enrollment in a new resource.

Secondary

MeasureTime frameDescription
Vaso-occlusive Episodes12 monthsNumber of painful vaso-occlusive episodes (VOE) requiring an ED or acute care clinic visit
Prescriptions for Sickle Cell Disease12 monthsData on prescriptions written and filled for hydroxyurea and penicillin will be collected through EHR review. . Number of days covered by prescriptions will be reported
Personal Health Questionnaire Depression Scale (PHQ-8)12 monthsPatient Health Questionnaire depression scale (PHQ-8) is an 8 item instrument with possible responses for each item of 0=Not at all, 1=Several days 2= More than half the days, 3=Nearly every day. The range of scores is 0 to 24. A score of 10 or greater is considered major depression, 20 or more is severe major depression.
White Blood Cell and Absolute Neutrophil Counts Related to Medication Adherence12 monthsLaboratory markers commonly affected by hydroxyurea medication from the CBC (complete blood count) including hemoglobin and hemoglobin F levels, white blood cell and absolute neutrophil counts, and mean corpuscular volume. Each will be abstracted from medical records.
Mean Corpuscular Volume Values Related to Medication Adherence12 monthsLaboratory markers commonly affected by hydroxyurea medication from the CBC (complete blood count) including hemoglobin and hemoglobin F levels, white blood cell and absolute neutrophil counts, and mean corpuscular volume (MCV) will be abstracted from medical records. MCV is a measure of the average volume of a red blood corpuscle (or red blood cell).
Hemoglobin Values Related to Medication Adherence12 monthsLaboratory markers commonly affected by hydroxyurea medication from the CBC (complete blood count) include hemoglobin and hemoglobin F levels, white blood cell and absolute neutrophil counts, and mean corpuscular volume. Each wil be abstracted from the medical records.
Brief COPE (Coping Orientation to Problems Experienced Inventory) at 12 Months12 monthsSelf-reported measure of effective and ineffective ways to cope with a stressful life event. 28 total items (list of coping behaviors) scored on a 4-point Likert scale from 1 (I haven't been doing this at all) to 4 (I've been doing this a lot). There are 14 coping behaviors for the 28 items and scores for each of the 14 can range from 1-8.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention-WE CARE
Received WE CARE screener and referral program
41
Control-Standard of Care
Received standard of care
49
Total90

Withdrawals & dropouts

PeriodReasonFG000FG001
12 Months FollowupLost to Follow-up1017
Completed Baseline AssessmentDid not complete baseline assessment1012

Baseline characteristics

CharacteristicIntervention-WE CAREControl-Standard of CareTotal
Age, Continuous37 years36 years37 years
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Acceptance
5.5 scores on a scale5 scores on a scale5 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Active coping
5 scores on a scale5 scores on a scale5 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Behavioral disengagement
2 scores on a scale2 scores on a scale2 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Denial
2 scores on a scale2 scores on a scale2 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Humor
2 scores on a scale2 scores on a scale2 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Planning
4 scores on a scale4 scores on a scale4 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Positive reframing
5.5 scores on a scale5 scores on a scale5 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Religion
6 scores on a scale6 scores on a scale6 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Self blame
2 scores on a scale2 scores on a scale2 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Self distraction
3 scores on a scale4 scores on a scale3.5 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Substance use
2 scores on a scale2 scores on a scale2 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Use of emotional support
4 scores on a scale4 scores on a scale4 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Use of instrumental support
4 scores on a scale4 scores on a scale4 scores on a scale
Brief Coping Orientation to Problems Experienced (COPE) Inventory at Baseline
Venting
2 scores on a scale3 scores on a scale3 scores on a scale
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants9 Participants14 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
30 Participants40 Participants70 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
6 Participants0 Participants6 Participants
Patient Health Questionnaire 8 (PHQ-8)
Major (10-19 points)
5 Participants5 Participants10 Participants
Patient Health Questionnaire 8 (PHQ-8)
None (0-9 points)
33 Participants42 Participants75 Participants
Patient Health Questionnaire 8 (PHQ-8)
Severe (≥ 20 points)
0 Participants2 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
29 Participants36 Participants65 Participants
Race (NIH/OMB)
More than one race
2 Participants8 Participants10 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
8 Participants4 Participants12 Participants
Race (NIH/OMB)
White
2 Participants1 Participants3 Participants
Region of Enrollment
United States
41 participants49 participants90 participants
Sex/Gender, Customized
Female
29 Participants43 Participants72 Participants
Sex/Gender, Customized
Male
7 Participants6 Participants13 Participants
Sex/Gender, Customized
Unknown
5 Participants0 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 410 / 49
other
Total, other adverse events
0 / 410 / 49
serious
Total, serious adverse events
0 / 410 / 49

Outcome results

Primary

Number of Emergency Department (ED)/Acute Care Visits

Data on number of ED visits and acute care visits abstracted from the EHR.

Time frame: 12 months

Population: EHR data abstraction was done at 12 months for all participants who completed the baseline assessment.

ArmMeasureValue (MEDIAN)
Intervention-WE CARENumber of Emergency Department (ED)/Acute Care Visits0 number of visits
Control-Standard of CareNumber of Emergency Department (ED)/Acute Care Visits1 number of visits
Primary

Parental Enrollment in Community Resources

Self-reported enrollment in a new community resource, where yes indicates enrollment in a new resource, and no indicates no enrollment in a new resource.

Time frame: 12 months

Population: Data are missing for 3 participants in the control arm.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention-WE CAREParental Enrollment in Community ResourcesEmployment1 Participants
Intervention-WE CAREParental Enrollment in Community ResourcesFood1 Participants
Intervention-WE CAREParental Enrollment in Community ResourcesChild care1 Participants
Intervention-WE CAREParental Enrollment in Community ResourcesEducation1 Participants
Intervention-WE CAREParental Enrollment in Community ResourcesHousing1 Participants
Intervention-WE CAREParental Enrollment in Community ResourcesUtilities5 Participants
Intervention-WE CAREParental Enrollment in Community ResourcesAny new resource9 Participants
Control-Standard of CareParental Enrollment in Community ResourcesUtilities7 Participants
Control-Standard of CareParental Enrollment in Community ResourcesAny new resource11 Participants
Control-Standard of CareParental Enrollment in Community ResourcesChild care2 Participants
Control-Standard of CareParental Enrollment in Community ResourcesEmployment0 Participants
Control-Standard of CareParental Enrollment in Community ResourcesHousing1 Participants
Control-Standard of CareParental Enrollment in Community ResourcesFood1 Participants
Control-Standard of CareParental Enrollment in Community ResourcesEducation2 Participants
Secondary

Brief COPE (Coping Orientation to Problems Experienced Inventory) at 12 Months

Self-reported measure of effective and ineffective ways to cope with a stressful life event. 28 total items (list of coping behaviors) scored on a 4-point Likert scale from 1 (I haven't been doing this at all) to 4 (I've been doing this a lot). There are 14 coping behaviors for the 28 items and scores for each of the 14 can range from 1-8.

Time frame: 12 months

Population: Data are missing for 1 participant in the intervention arm and 4 participants in the control arm

ArmMeasureGroupValue (MEDIAN)
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsSelf-distraction2 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsActive copying4 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsDenial2 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsSubstance use2 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsUse of emotional support3 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsUse of instrumental support2 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsBehavioral engagement2 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsVenting2 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsPositive reframing4.5 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsPlanning4 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsHumor2 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsAcceptance6 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsReligion4.5 score on a scale
Intervention-WE CAREBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsSelf-blame2 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsHumor2 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsSelf-distraction3.5 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsVenting2 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsActive copying5 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsReligion6.5 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsDenial2 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsPositive reframing4 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsSubstance use2 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsAcceptance6 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsUse of emotional support4 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsPlanning4 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsUse of instrumental support4 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsSelf-blame2 score on a scale
Control-Standard of CareBrief COPE (Coping Orientation to Problems Experienced Inventory) at 12 MonthsBehavioral engagement2 score on a scale
Secondary

Hemoglobin Values Related to Medication Adherence

Laboratory markers commonly affected by hydroxyurea medication from the CBC (complete blood count) include hemoglobin and hemoglobin F levels, white blood cell and absolute neutrophil counts, and mean corpuscular volume. Each wil be abstracted from the medical records.

Time frame: 12 months

Population: EHR data abstraction was done at 12 months for all participants who completed the baseline assessment.

ArmMeasureValue (MEDIAN)
Intervention-WE CAREHemoglobin Values Related to Medication Adherence9.3 g/dL
Control-Standard of CareHemoglobin Values Related to Medication Adherence8.8 g/dL
Secondary

Mean Corpuscular Volume Values Related to Medication Adherence

Laboratory markers commonly affected by hydroxyurea medication from the CBC (complete blood count) including hemoglobin and hemoglobin F levels, white blood cell and absolute neutrophil counts, and mean corpuscular volume (MCV) will be abstracted from medical records. MCV is a measure of the average volume of a red blood corpuscle (or red blood cell).

Time frame: 12 months

Population: EHR data abstraction was done at 12 months for all participants who completed the baseline assessment.

ArmMeasureValue (MEDIAN)
Intervention-WE CAREMean Corpuscular Volume Values Related to Medication Adherence96 femtoliters (10^15; fl)
Control-Standard of CareMean Corpuscular Volume Values Related to Medication Adherence90.1 femtoliters (10^15; fl)
Secondary

Personal Health Questionnaire Depression Scale (PHQ-8)

Patient Health Questionnaire depression scale (PHQ-8) is an 8 item instrument with possible responses for each item of 0=Not at all, 1=Several days 2= More than half the days, 3=Nearly every day. The range of scores is 0 to 24. A score of 10 or greater is considered major depression, 20 or more is severe major depression.

Time frame: 12 months

Population: Data are missing for 1 intervention participant and 4 control participants.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention-WE CAREPersonal Health Questionnaire Depression Scale (PHQ-8)None (0-9 points)28 Participants
Intervention-WE CAREPersonal Health Questionnaire Depression Scale (PHQ-8)Major (10-19 points)1 Participants
Intervention-WE CAREPersonal Health Questionnaire Depression Scale (PHQ-8)Severe (≥ 20 points)1 Participants
Control-Standard of CarePersonal Health Questionnaire Depression Scale (PHQ-8)None (0-9 points)25 Participants
Control-Standard of CarePersonal Health Questionnaire Depression Scale (PHQ-8)Major (10-19 points)3 Participants
Control-Standard of CarePersonal Health Questionnaire Depression Scale (PHQ-8)Severe (≥ 20 points)0 Participants
Secondary

Prescriptions for Sickle Cell Disease

Data on prescriptions written and filled for hydroxyurea and penicillin will be collected through EHR review. . Number of days covered by prescriptions will be reported

Time frame: 12 months

Population: EHR data abstraction was done at 12 months for all participants who completed the baseline assessment except for 1 participant in the intervention group and for 2 participants in the control group; for those 3 participants the data are missing.

ArmMeasureGroupValue (MEDIAN)
Intervention-WE CAREPrescriptions for Sickle Cell DiseasePenicillin365 days
Intervention-WE CAREPrescriptions for Sickle Cell DiseaseHydroxurea365 days
Control-Standard of CarePrescriptions for Sickle Cell DiseasePenicillin196 days
Control-Standard of CarePrescriptions for Sickle Cell DiseaseHydroxurea258 days
Secondary

Vaso-occlusive Episodes

Number of painful vaso-occlusive episodes (VOE) requiring an ED or acute care clinic visit

Time frame: 12 months

Population: EHR data abstraction was done at 12 months for all participants who completed the baseline assessment.

ArmMeasureValue (MEDIAN)
Intervention-WE CAREVaso-occlusive Episodes1 number of episodes
Control-Standard of CareVaso-occlusive Episodes1 number of episodes
Secondary

White Blood Cell and Absolute Neutrophil Counts Related to Medication Adherence

Laboratory markers commonly affected by hydroxyurea medication from the CBC (complete blood count) including hemoglobin and hemoglobin F levels, white blood cell and absolute neutrophil counts, and mean corpuscular volume. Each will be abstracted from medical records.

Time frame: 12 months

Population: EHR data abstraction was done at 12 months for all participants who completed the baseline assessment.

ArmMeasureGroupValue (MEDIAN)
Intervention-WE CAREWhite Blood Cell and Absolute Neutrophil Counts Related to Medication AdherenceWhite blood cell count (per dL)8.6 cells per dL
Intervention-WE CAREWhite Blood Cell and Absolute Neutrophil Counts Related to Medication AdherenceAbsolute neutrophil count (per dL)3.5 cells per dL
Control-Standard of CareWhite Blood Cell and Absolute Neutrophil Counts Related to Medication AdherenceWhite blood cell count (per dL)9.0 cells per dL
Control-Standard of CareWhite Blood Cell and Absolute Neutrophil Counts Related to Medication AdherenceAbsolute neutrophil count (per dL)3.4 cells per dL

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026